Syndax Pharmaceuticals, Inc. - Common Stock — 재무제표 (NASDAQ:SNDX) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 300.61 M449.66 M497.24 M612.88 M724.82 M529.71 M 총 부채 48.42 M41.29 M29.79 M58.68 M436.69 M465.08 M 자본금 총액 252.19 M408.37 M467.45 M554.2 M288.12 M64.63 M 총 부채 및 주주자본 300.61 M449.66 M497.24 M612.88 M724.82 M529.71 M 총부채 20.12 M19.89 M0—675.25 M— 순부채 -272.95 M-420.04 M-475.8 M—102.36 M—

뉴스

Syndax Pharmaceuticals (SNDX) Reports Q1 Loss, Misses Revenue Estimates

Nuvation Bio Inc. (NUVB) Reports Next Week: Wall Street Expects Earnings Growth

Kura Oncology: Commercialization In AML Presents Asymmetric Upside (NASDAQ:KURA)

Syndax Pharmaceuticals, Inc. (SNDX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Syndax, Barclays 컨퍼런스 참가: 전략적 성장 집중

Syndax Pharmaceuticals at Barclays Conference: Strategic Growth Focus

Syndax, Leerink 컨퍼런스서 전략적 성장 및 수익성 강조

Syndax at Leerink Conference: Strategic Growth and Profitability

신닥스 제약, 52주 최고가 $22.91 기록

Syndax Pharmaceuticals stock hits 52-week high at $22.91

Syndax, TD Cowen 컨퍼런스서 전략적 성장 및 재무 건전성 강조

Syndax at TD Cowen Conference: Strategic Growth and Financial Strength